View Clinical Trial (Medical Research Study)


Novel Diagnostics With Optical Coherence Tomography: Retinal Imaging - NCT00343746-15213(Clinical Trial 146123)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Pittsburgh
State:  
PA
Zip Code: 15213
Conditions: Macular Degeneration - Glaucoma - Diabetic Retinopathy.
Purpose: The purpose of this research is to evaluate optical coherence tomography (OCT) and FDA approved device used to image diseases of the eye. The ultra-high resolution OCT is a non-significant risk device used in this study. Optical Coherence Tomography may be useful for early diagnosis and monitoring of different types of eye diseases.
Study summary: The purpose of this research is to evaluate optical coherence tomography (OCT) and FDA approved device used to image diseases of the eye. The ultra-high resolution OCT is a non-significant risk device used in this study. OCT may be useful for early diagnosis and monitoring of different types of eye diseases.
Criteria: Inclusion Criteria: - Subjects with healthy eyes, macular degeneration, glaucoma and other various eye diseases. Also must be able to fixate on target. Exclusion Criteria: - If the fundus is not visible if the media is opaque and if they are unwilling to participate.
Study is available at: University of Pittsburgh UPMC Eye Center
Pittsburgh, PA 15213
United States

Primary Contact:
Kristy A Truman
Email: trumank@upmc.edu
Phone: 412-647-3971
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 21, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.